( April 4, 2025, 14:11 GMT | Official Statement) -- MLex Summary: The Unified Patent Court ruled in favor of Edwards Lifesciences Corporation, granting an injunction against Meril Life Sciences for infringing European Patent 3,669,828 related to prosthetic heart valve technology. The Local Division Mannheim rejected Meril's preliminary objections and counterclaim for revocation, affirming the patent's validity and finding that Meril's "Myval" heart valve product and "Navigator" delivery system literally infringed the patent claims. Edwards was granted relief, including a cease-and-desist order, information disclosure and provisional damages. The decision is immediately enforceable, with Meril held liable for costs incurred by Edwards.See court document attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.